Melanoma Vaccines: Breakthrough or Bust?
- 1 January 2002
- journal article
- Published by Taylor & Francis in Cancer Investigation
- Vol. 20 (7-8) , 1114-1116
- https://doi.org/10.1081/cnv-120005930
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Adjuvant Immunotherapy of Resected, Intermediate-Thickness, Node-Negative Melanoma With an Allogeneic Tumor Vaccine: Overall Results of a Randomized Trial of the Southwest Oncology GroupJournal of Clinical Oncology, 2002
- Melanoma VaccinesCancer Investigation, 2002
- High-Dose Interferon Alfa-2b Significantly Prolongs Relapse-Free and Overall Survival Compared With the GM2-KLH/QS-21 Vaccine in Patients With Resected Stage IIB-III Melanoma: Results of Intergroup Trial E1694/S9512/C509801Journal of Clinical Oncology, 2001
- Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.Journal of Clinical Oncology, 1996